• Advances in hepatitis B therapeutics 

      Soriano, Vicente (1); Barreiro, Pablo; Cachay, Edward R.; Kottilil, Shyamasundaran; Fernandez-Montero, José V.; Mendoza, Carmen de (Therapeutic Advances in Infectious Disease, 10/2020)
      Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million people are chronically infected with the hepatitis B virus (HBV). Globally, chronic hepatitis B is the leading cause of ...
    • Envisioning a hepatitis delta cure with new antivirals 

      Soriano, Vicente (1); Mendoza, Carmen de; Barreiro, Pablo; Treviño, Ana (1); Corral, Octavio Jorge (1) (Future Medicine Ltd., 2021)
      Envisioning a hepatitis delta cure with new antivirals
    • Hepatitis delta in patients hospitalized in Spain (1997-2018) 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; Ramos-Belinchón, Clara; de Mendoza, Carmen; Aguilera, Antonio; Soriano, Vicente (1) (NLM (Medline), 2021)
      BACKGROUND: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the ...
    • Hepatitis delta in patients with resolved hepatitis B virus infection 

      Aguilera, Antonio; Rodríguez-Calviño, Javier; Mendoza, Carmen de; Soriano, Vicente (1) (European Journal of Gastroenterology & Hepatology, 09/2018)
      Background The hepatitis delta virus (HDV) causes the most aggressive form of chronic viral hepatitis. As HDV replication requires hepatitis B virus (HBV), HDV screening is limited to HBsAg+ carriers. To date, individuals ...
    • Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain 

      Aguilera, Antonio; Trastoy, Rocío; Rodríguez-Calviño, Javier; Manso, Tamara; Mendoza, Carmen de; Soriano, Vicente (1) (European Journal of Gastroenterology & Hepatology, 09/2018)
      Background Hepatitis delta virus (HDV) is a defective agent that only replicates in the presence of the hepatitis B virus. Accordingly, HDV acquisition may occur as superinfection of HBsAg+ carriers or following acute dual ...